Fair Value Calculator Fair Value Calculator
EN DE

IKAB (IKAB) Fair Value & Analysis

Financials · IN · Market cap ₹3.5B

I IKAB IKAB · BSE
Price₹1,190
Fair Value₹203.09
Upside-82.9%
Quality55/100
Watch IKAB for free — get notified when fair value or trend changes. Watch for free
Evidence: Medium Range ₹152.32 – ₹253.86

Fair value as of: Jul 5, 2026

From 15 valuation models · updated today

Share price +26.5% over the past month.

Price vs Fair Value (12 months)

₹1,739 ₹748.10 Fair Value ₹203.09 Jun 2025 Jul 2026

12‑month range ₹748.10 – ₹1,739 · fair‑value band ₹152.32 – ₹253.86 · the ₹1,190 price screens above the ₹203.09 fair value. As of Jul 5, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

IKAB (IKAB) currently trades at ₹1,190, while our model-based Fair Value estimate is ₹203.09 — implying the stock looks roughly 82.9% overvalued today. We read business quality at 55/100 (solid quality), in the Financials sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: medium).

Our scenario range runs from ₹152.32 (bear case) to ₹253.86 (bull case); at ₹1,190, the current price sits above that range. The share trades about 34% below its 52-week high and 63% above its 52-week low. For context, the median of 10 Financials peers we cover trades at 83% fair-value upside — at -83%, IKAB screens richer than that median.

Revenue & earnings trend

FY2019 – FY2022 · reported fiscal years

IKAB reported revenue of ₹137M in FY2022 versus ₹896M in FY2019, a compound −46.5%/yr. Reported net income was ₹45.7M in FY2022.

Revenue −46.5%/yr
FY19 ₹896M
FY20 ₹21.3M
FY21 ₹83.0M
FY22 ₹137M
Net income
FY19 −₹142K
FY20 −₹14.7M
FY21 ₹27.0M
FY22 ₹45.7M

Is IKAB fairly valued? → Check now

🧮 Run the numbers yourself — free valuation calculators
📤 Share or link this analysis
🔗 Embed on your site (free fair-value badge)

Paste this into your site or blog — it shows the current fair value and links back here (free, and welcome):

Cite: Fair Value Calculator (2026). "IKAB Fair Value". https://www.fairvalue-calculator.com/stock/IKAB

Similar stocks

10 more Investment Banking & Investment Services stocks, each showing price versus our Fair Value estimate (as of Jul 5, 2026).

Stock Price Fair Value vs Fair Value
Affiliated Managers Group MGR $20.32 $38.45 +89%
Mirae Asset Venture Investment Co 100790 39,800 KRW 12,853 KRW -68%
Hercules Capital, Inc HCXY $25.00 $50.00 +100%
Aju IB Investment Co 027360 5,260 KRW 996.70 KRW -81%
EBEST Investment & Securities Co 078020 6,290 KRW 11,532 KRW +83%
PSE PSE 210.00 PHP 141.12 PHP -33%
V V 0.8900 PHP 1.42 PHP +60%
Lindeman Asia Investment Co 277070 3,060 KRW 2,272 KRW -26%
SERA SERA ₹40.61 ₹81.22 +100%
ABA ABA 0.3100 PHP 0.6200 PHP +100%

Explore undervalued stocks

More undervalued Financial Services stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap Stocks

Frequently asked questions

Is IKAB (IKAB) undervalued?
As of Jul 5, 2026, our model estimates a fair value of ₹203.09 versus a price of ₹1,190 — about −83% (overvalued). Model-based estimate, not financial advice.
What is the fair value of IKAB?
Our model-based fair value for IKAB is ₹203.09 (as of Jul 5, 2026), built from audited fundamentals. The current price is ₹1,190.
What is the quality score of IKAB?
IKAB has a Quality Score of 55/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.
What is the net profit margin of IKAB?
The net profit margin of IKAB is about 0.0%, meaning it keeps roughly 0.0% of revenue as net income. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.